SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 29, 2003
NEOSE TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)
| Delaware |
0-27718 |
13-3549286 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
| 102 Witmer Road, Horsham, Pennsylvania |
19044 | |
| (Address of principal executive offices) |
(Zip Code) |
Registrant’s telephone number, including area code: (215) 315-9000
Item 5. Other Events.
Announcement of License. On April 29, 2003, Neose Technologies, Inc. (the “Company”) announced that it has signed a license agreement with GlaxoSmithKline.
Item 7. Financial Statements, Pro Forma Financial Information And Exhibits.
(a) Financial Statements of Businesses Acquired: None
(b) Pro Forma Financial Information: None
(c) Exhibits: Reference is made to the Exhibit Index annexed hereto and made a part hereof.
-2-
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| NEOSE TECHNOLOGIES, INC. | ||
| By: |
/s/ C. BOYD CLARKE | |
| C. Boyd Clarke President and Chief Executive Officer | ||
Dated: April 29, 2003
EXHIBIT INDEX
| Exhibit No. |
Description | |
| 99.1 |
Press release issued on April 29, 2003 by Neose Technologies, Inc. |
-2-